Luckin Coffee Inc. (LKNCY) stock: insider buying, earnings and risk | BrightDollar

Luckin Coffee Inc. · Eating & Drinking Places

LKNCY

Low riskNext report: Not enough history

The short version

A profitable company with growing sales.

Going well

Profitable
Sales up 49% last year
Brings in more cash than it spends

Money moves

No insider buying or selling in the last 30 days
Institutions cut 3.6% from their holdings in the quarter ending June 2026 (3 bought, 3 sold)

Facts from SEC filings, not a recommendation.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/6Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.27.0%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.7.3%
MissProfitable every yearSteady profits, not one good year.5 of 7 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$494.9M
MissShare count not growingNot diluting owners. Falling means buybacks.+2.1% in 3 years

Revenue: $7.0B; +48.9% vs prior year
5-year growth: +62.6%/yr; revenue, per year
Total debt: None; 0.00x equity
Current ratio: 1.70x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 0.8
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady-3.6%

Institutions cut 3.6% from their holdings. 3 bought, 3 sold. 2 quarters of net selling in a row.

Shares held by institutions17K

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+0.7%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

2.6B

Earnings reports

Last 0

Next reportNot enough history

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (active)Sep 9 · View filing ↗Activist

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

New insiderOct 14 · Form 3 ↗6-KSep 29 · Form 6-K ↗5%+ holder update (active)Sep 9 · Form SCHEDULE 13D/A ↗Planned insider saleSep 2 · Form 144 ↗6-KSep 1 · Form 6-K ↗

SoldJinyi GuoChief Executive Officer, Director

296,671 shares at $36.45 avg ($36.20 to $36.50) · $10.8M

-39% of holdings
Now owns 461,099 shares
Not a pre-planned sale
2 transactions
Filed 1 day after trade

Aug 6Form 4 ↗

SoldWenbao CaoSenior Vice President, Director

150,000 shares at $37.06 avg ($37.00 to $37.10) · $5.6M

-44% of holdings
Now owns 190,482 shares
Not a pre-planned sale
3 transactions
Filed 2 days after trade

Aug 4Form 4 ↗

Planned insider saleAug 5 · Form 144 ↗Planned insider saleAug 4 · Form 144 ↗6-KAug 3 · Form 6-K ↗

SoldJing AnChief Financial Officer

1,760 shares at $30.72 · $54K

-1% of holdings
Now owns 275,784 shares
Not a pre-planned sale
Filed 2 days after trade

Jun 9Form 4 ↗

SoldJing AnChief Financial Officer

6,756 shares at $32.45 · $219K

-2% of holdings
Now owns 277,544 shares
Not a pre-planned sale
Filed 2 days after trade

Jun 2Form 4 ↗

New 5%+ holder (passive)May 22 · Form SCHEDULE 13G ↗6-KMay 20 · Form 6-K ↗

SoldJing AnChief Financial Officer

200 shares at $33.23 · $7K

-0% of holdings
Now owns 284,300 shares
Not a pre-planned sale
Filed 4 days after trade

May 14Form 4 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page